Hematology

Hematology

Predicting cardiac issues in cancer survivors using a serum protein panel test

LABline

Dec. 4, 2024

Finding noninvasive, effective ways to predict disease risk is a tremendous challenge.

Value of a Chromatogram in Hemoglobin A1C Testing

Nov. 13, 2024

Hematology

Routine blood test can identify laboring women at risk for preeclampsia

LABline

Oct. 22, 2024

Hematology

Experimental blood test improves early detection of pancreatic cancer

LABline

Oct. 9, 2024

Hematology

Experimental blood test predicts risk for developing COPD, other severe respiratory diseases

LABline

Sept. 11, 2024

Hematology

Single blood test predicts 30-year cardiovascular disease risks for women

LABline

Sept. 3, 2024

Hematology

Dedicated laboratory automation for hemostasis testing

Anthony M. Barresi

Aug. 26, 2024

Now more than ever, laboratories are tasked with the combined aim of maximizing test volume and reliability, while minimizing turnaround time (TAT) and cost. Automation is an ...

Hematology

ApoB test may be more accurate measure of heart disease risk

LABline

Aug. 19, 2024

U.S. guidelines may miss vulnerable patients whose cholesterol levels appear within healthy range, UTSW researchers find.

Hematology

Safety and phlebotomy: Considerations for a common invasive procedure

Tammy Oppy, BS, MLS(ASCP)

July 22, 2024

Phlebotomy — collecting a blood specimen directly from the circulatory system via puncture for analysis and diagnosis — is one of the most common invasive procedures...

Hematology

HORIBA launches new compact hematology analyzers with combined ESR and CBC/DIFF

LABline

June 24, 2024

Yumizen H550 range expands to affordably introduce new applications and configurable hematology options for small to mid-throughput laboratories.

Hematology

Best practices in preanalytical sample quality: Managing and preventing in vitro hemolysis in the emergency department

Kim Skala, MLS(ASCP)

June 24, 2024

Laboratory errors can lead to errors in diagnosis and may cause increased costs, unnecessary testing and/or treatment, and adverse patient outcomes. Approximately 60–70%...

Hematology

Blood-based MRD test for cancer recurrence can generate cost savings in colorectal cancer treatment, finds study in JAMA Health Forum

LABline

June 3, 2024

Circulating tumor DNA (ctDNA) testing for minimal residual disease (MRD) can reduce costs by up to 21% across health plan populations when half of eligible patients with stage...

Hematology

Vitestro shares trial results at WorldLab 2024 confirming performance, safety and patient acceptance for breakthrough autonomous blood drawing technology

LABline

May 29, 2024

All performance and safety endpoints were met in A.D.O.P.T. Pivotal Trial Study Phase; other key findings include 95% first-stick success and 98% patient acceptance.

Hematology

Thermo Fisher Scientific introduces array-based solution for extended blood type research to support future advancements toward safer transfusions

LABline

May 20, 2024

For more information, please visit thermofisher.com/extendedbloodtyping and read the white paper, “Genotyping for extended and rare blood types.”

Hematology

Transforming infection detection with the CBC-Diff

Melissa Naiman, PhD, EMT-B

March 25, 2024

In a world overpopulated by pathogens, the human immune system has evolved to protect against pathogens that are, themselves, continually evolving. Host immune response to infection...